mRNA COVID Vaccines Linked to Improved Survival in Cancer Patients, Study Reveals
Cancer patients who received mRNA COVID-19 vaccines showed significantly improved survival rates, new research suggests. The findings point to broader immune benefits beyond coronavirus protection that could influence cancer treatment approaches.
Unexpected Cancer Survival Benefit
Patients undergoing treatment for advanced skin and lung cancer lived longer if they had received Moderna or Pfizer COVID-19 vaccines, according to new research published in the journal Nature. The surprising findings suggest these widely available mRNA vaccines may provide benefits beyond their intended coronavirus protection, sources indicate.
